24-hour IOP-lowering Effect of Brimonidine 0.1%

NCT00457795 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-angle Glaucoma
Ocular Hypertension

Interventions

DRUG: brimonidine 0.1% (Alphagan® P)

Sponsor

Allergan